|
Generic:
|
| Rosuvastatin, Ezetimibe |
| |
|
Therapeutic Class:
|
|
Lipid Modifying Agents, Combinations
|
| |
|
Composition:
|
- Rozet EZ Tab 5 mg / 10 mg: Each tablet contains 5 mg Rosuvastatin and 10 mg Ezetimibe.
- Rozet EZ Tab 10 mg / 10 mg: Each tablet contains 10 mg Rosuvastatin and 10 mg Ezetimibe.
- Rozet EZ Tab 20 mg / 10 mg: Each tablet contains 20 mg Rosuvastatin and 10 mg Ezetimibe.
|
| |
|
Description:
|
|
Rozet EZ tablets contain rosuvastatin calcium and ezetimibe. Rosuvastatin is a 3-hydroxy-3methylglutaryl coenzyme A (HMG CoA)-reductase inhibitor. Ezetimibe is a dietary cholesterol absorption inhibitor.
|
| |
|
Indications:
|
- As an adjunct to diet in patients with primary non-familial hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C).
- Alone or as an adjunct to other LDL-C-lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C.
|
|
|
Dosage:
|
The dosage range is 5 mg/10 mg to 40 mg/10 mg once daily.
- The recommended dose of Rozet EZ depends on a patient’s indication for usage, LDL-C, and individual risk for cardiovascular events.
- The starting dosage for patients switching to Rozet EZ from co-administration of a statin and ezetimibe is based on an equivalent dose of rosuvastatin and 10 mg of ezetimibe.
- Assess LDL-C when clinically appropriate, as early as 2 weeks after initiating Rozet EZ, and adjust the dosage if necessary.
|
|
|
Presentations:
|
- Rozet EZ Tab 5 mg /10 mg is available in a pack of 10’s
- Rozet EZ Tab 10 mg /10 mg is available in a pack of 10’s
- Rozet EZ Tab 20 mg /10 mg is available in a pack of 10’s
|
|
|
|
|
